J Gen Virol Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 85 (2004), 2023-2034; DOI 10.1099/vir.0.19696-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, J.-C.
Right arrow Articles by Lee, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, J.-C.
Right arrow Articles by Lee, S. P.
Agricola
Right arrow Articles by Lin, J.-C.
Right arrow Articles by Lee, S. P.
© 2004 Society for General Microbiology

Amino acid changes in functional domains of latent membrane protein 1 of Epstein–Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted ‘epitope-loss variant’

Jung-Chung Lin1, Jaw-Ming Cherng2, Hsiung-Ju Lin3, Chi-Wai Tsang4, Yi-Xi Liu5 and Steven P. Lee4

1 Department of Microbiology, Tzu Chi University School of Medicine, 701 Section 3, Chung Yang Road, Hualien 970, Taiwan, ROC
2 Department of Internal Medicine, Tzu Chi General Hospital, Hualien, Taiwan, ROC
3 Department of Pathology, Kaohsiung Medical University, China
4 CRC Institute for Cancer Studies, University of Birmingham, Birmingham, UK
5 Department of Virology, Cancer Research Institute, Chinese Academy of Medical Sciences, Beijing, China

Correspondence
Jung-Chung Lin
jclin{at}mail.tcu.edu.tw

Full-length sequences of the Epstein–Barr virus (EBV) gene for latent membrane protein (LMP)-1 from 22 nasopharyngeal carcinoma (NPC) biopsy specimens and 18 non-neoplastic counterparts (NPI) were determined. Relative to the B95-8 strain, the amino acid sequences of the toxic-signal and transformation domains were changed variably in NPC and NPI specimens; in contrast, no change was observed in the NF-{kappa}B (nuclear factor {kappa}B) activation domain. HLA typing revealed that 47 % of NPC and 31 % of NPI specimens were HLA A2-positive. A major A2-restricted epitope within LMP-1 (residues 125–133) was analysed. At residue 126, a change of L->F was detected in 91 % (20/22) of NPC and 67 % (12/18) of NPI specimens. In addition, a deletion at residue 126 was detected in one NPC sample from Taiwan. At residue 129, a change of M->I was observed in all samples, regardless of whether they were NPC or NPI. The changes in this peptide between NPC and NPI specimens, including mutation and deletion, are statistically significant (P<0·05). A recent report indicated that this variant sequence is recognized poorly by epitope-specific T cells. Genotyping results indicated that 96 % of NPC and 67 % of NPI samples carried a type A virus. By scanning the entire sequence of LMP-1, eight distinct patterns were identified. Detailed examination of these patterns revealed that type A strains are more prevalent in NPC than in NPI specimens and are marked by the loss of an XhoI site, the presence of a 30 bp deletion and the presence of a mutated, A2-restricted, T cell target epitope sequence. These results suggest that an EBV strain carrying an HLA A2-restricted ‘epitope-loss variant’ of LMP-1 is prevalent in NPC in southern China and Taiwan.




This article has been cited by other articles:


Home page
Lab AnimHome page
K.-P. N Chow, C C Wu, H Y Chang, C Chang, and Y S Chang
A simplified tumour model established via Epstein-Barr virus-encoded, nasopharyngeal carcinoma-derived oncogene latent membrane protein 1 in immunocompetent mice
Lab Anim, April 1, 2008; 42(2): 193 - 203.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Pandya and D. M. Walling
Oncogenic Activity of Epstein-Barr Virus Latent Membrane Protein 1 (LMP-1) Is Down-Regulated by Lytic LMP-1.
J. Virol., August 1, 2006; 80(16): 8038 - 8046.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2004 by the Society for General Microbiology.